Race and the treatment of cytomegalovirus retinitis in a cohort of patients with acquired immunodeficiency syndrome

Journal of the National Medical Association

Volumn 90, Issue 4, 1998, Pages 214-220

  Wutoh, Anthony K ^a   Hidalgo, Julia ^b   Bareta, Joseph ^b   Rhee, Alter ^b   Beardsley, Robert ^b   Steidl, Scott ^b  

^a HOWARD UNIVERSITY   (United States)

^b NONE

Author keywords

Acquired immunodeficiency syndrome; Cytomegalovirus retinitis; Race

Indexed keywords

ADULT; AFRICAN AMERICAN; AIDS RELATED COMPLEX; ARTICLE; FEMALE; HUMAN; MALE; RETINITIS; SOCIOECONOMICS; UNITED STATES;

ADULT; AFRICAN AMERICANS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CYTOMEGALOVIRUS RETINITIS; FEMALE; HUMANS; MALE; MARYLAND; SOCIOECONOMIC FACTORS;

EID: 0032042614     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. AIDS Administration, Maryland Department of Health and Mental Hygiene. Maryland AIDS Update. Baltimore, Md: Maryland Dept of Health and Mental Hygiene; 1995.
2. Stone VE, Weissman JS, Cleary PD. Satisfaction with ambulatory care of persons with AIDS. Predictors of patient ratings of quality. J Gen Intern Med. 1995;10:239-245.
3. Brunswick AF, Aidala A, Dobkin J, Howard J, Titus SP, Banaszak-Holl J. HIV-1 seroprevalence and risk behaviors in an urban African-American community cohort. Am J Public Health. 1993;83:1390-1394.
4. Drew WL, Ives D, Lalezari JP, Crumpacker C, Follansbee SE, Spector SA, et al. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. N Engl J Med. 1995;333:615-620.
5. Study of Ocular Complications of AIDS (SOCA). Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med. 1992;326:213-220.
6. Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and AIDS. Arch Ophthalmol. 1989;107:75-80.
7. Crumpacker CS, Heath-Chiozzi M. Overview of cytomegalovirus infections in HIV-infected patients. Current therapies and future strategies. J Acquir Immune Defic Syndr Hum Retravirol. 1991;4(suppl 1):S1-S5.
8. Schooley RT. Cytomegalovirus in the setting of infection with HIV. Reviews of Infectious Diseases. 1990;12:S811-S819.
9. Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med. 1995;333:751-756.
10. Farrell PC. The effect of gender and race on access to and utilization of care for HIV positive clients. Presented at the 11th International Conference on AIDS; 1996; Vancouver, Wash. July 7-12, 1996.
11. von Overbeck J, Egger M, Smith GD, Schoep M, Ledergerber B, Furrer H, et al. Survival in HIV infection: do sex and category of transmission matter? AIDS. 1994;8:1307-1313.
12. Hidalgo J. Development of a model longitudinal data base to measure outcomes and quality of care among persons with AIDS. Quality Review Bulletin. 1990.
13. Moore RD, Hidalgo J, Sugland BW, Chaison RE. Zidovudine and the natural history of the acquired immunodeficiency syndrome. N Engl J Med. 1991;324:1412-1416.
14. Hidalgo J. Development and application of statewide AIDS information systems in health services planning and evaluation. Evaluation and Program Planning. 1990;13:39-46.
15. Hidalgo J. Collecting statewide data on HIV costs and financing: pitfalls and payoffs. In: LeVee WN, ed. Conference Proceedings, New Perspectives on HIV-Related Illnesses: Progress in Health Services Research, May 17-19, 1990. Rockville, Md: National Center for Health Services Research and Health Care Technology Assessment; 1-10.
16. Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration With the AIDS Clinical Trials Group (ACTG). Studies of ocular complications of AIDS foscarnet-ganciclovir cytomegalovirus retinitis trial, I: rationale, design, and methods. Control Clin Trials. 1992;13:22-39.
17. Lieu TA, Newacheck PW, McManus MA. Race, ethnicity, and access to ambulatory care among US adolescents. Am J Public Health. 1993;83:960-965.
18. Cancela V De La. Minority AIDS prevention: moving beyond cultural perspectives towards sociopolitical empowerment. AIDS Educ Prev. 1989;1:141-153.
19. Moore RD, Hidalgo J, Bareta JC, Chaisson RE. Zidovudine therapy and health resource utilization in AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1994;7:349-354.
20. Friedland GH, Saltzman B, Vileno J, Freeman K, Schrager LK, Klein RS. Survival differences in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1991;4:144-153.
21. Moore RD, Stanton D, Gopalan R, Chaisson RE. Racial differences in the use of drug therapy for HIV disease in an urban community. N Engl J Med. 1994;330:763-768.